CTMX icon

CytomX Therapeutics

111 hedge funds and large institutions have $561M invested in CytomX Therapeutics in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 40 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

9% less funds holding

Funds holding: 122111 (-11)

20% less capital invested

Capital invested by funds: $698M → $561M (-$137M)

38% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 26

Holders
111
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$169K
Puts
$2K
Net Calls
Net Calls Change

Top Buyers

1 +$32.5M
2 +$13.7M
3 +$4.48M
4
PA
Perceptive Advisors
New York
+$3.74M
5
AG
Artal Group
Luxembourg
+$2.27M

Top Sellers

1 -$15.8M
2 -$12.4M
3 -$6.67M
4
Franklin Resources
Franklin Resources
California
-$6.17M
5
CC
Casdin Capital
New York
-$3.84M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$89.5M
2
$61.8M
3
$58.3M
4
$43.6M
5
$40.4M
6
$23.3M
7
$22.1M
8
$22M
9
$19.9M
10
$13.9M
11
$13.7M
12
$9.4M
13
$8.56M
14
$8.56M
15
$8.15M
16
$7.92M
17
$7.52M
18
$7.41M
19
$4.54M
20
$4.49M
21
$4.48M
22
$4.13M
23
$3.84M
24
$3.18M
25
$2.87M